Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284594 · ClinicalTrials.gov registry record · NA
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
A NA study of Influenza, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 4,026
- Enrollment target
- 1
- Study location
NCT02284594: Completed NA study of Influenza, sponsored by Columbia University.
NCT02284594 is a NA study of Influenza that has completed, run by Columbia University. The registered enrollment target is 4,026 participants, below the 36,778-participant average among 156 other Influenza trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02284594, a NA study of Influenza, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,026 participants
- Enrollment target
- 1
- Study location
Study Summary
Influenza infection leads to on average 3000-49,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low. Latino adults have the lowest coverage rates. Text message reminders have been used successfully for improving influenza vaccination for children. This study will assess the use of text messaging to improve influenza vaccination coverage rates in a largely minority, publicly insured adult population. We will also assess if the patient having received a text message makes the patient more likely to accept vaccination when their provider has received in electronic alert regarding need for influenza vaccination in the electronic health record.
Primary Outcome
receipt of influenza vaccine
Conditions Studied
Interventions
- BEHAVIORAL text message
Study Locations (1)
New York
- Columbia University Medical Center/ NewYork Presbyterian Hospital Ambulatory Care Network - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,026 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT02284594 record still lists
NCT02284594 is an interventional study that assigns participants to a tested intervention. Its 4,026 participants enrollment target places it among the larger protocols in the corpus, below the 36,778-participant average among 156 other Influenza trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which text message is the first listed.
NCT02284594 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02284594 about?
NCT02284594 is a clinical study titled "Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts". Influenza infection leads to on average 3000-49,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low. Latino adults have the lowest coverage rates. Text message reminders have been used succes...
What is the current status of trial NCT02284594?
This trial is currently completed. It is a NA study. The enrollment target is 4,026 participants. The study started on 2014-11. Estimated completion is 2015-03.
What conditions does trial NCT02284594 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT02284594?
The interventions under investigation include: text message (BEHAVIORAL).
Who is sponsoring clinical trial NCT02284594?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02284594 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02284594's enrollment target sits among peer trials
4,026 22nd of 156 higher than 135 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia